This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Just a few days after PerkinElmer officials said that the firm’s acquisition priorities begin with expanding its genetic testing business, the firm this week agreed to buy ViaCell, a Cambridge, Mass.-based specialty stem cell company, for around $300 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.